Catalyst News and Research

RSS

Collaborative Drug Discovery receives additional grant for TB drug research

Collaborative Drug Discovery, Inc. (CDD) today announced that the Bill & Melinda Gates Foundation has extended its previous grant to CDD to create a novel database to spark collaborative efforts to discover more effective drugs against tuberculosis (TB). The TB bacillus infects approximately one third of the world's population and the disease kills over 1.5 million people every year.

From Collaborative Drug Discovery, Inc. 14 Jan 2011

Therapeutic workshops selected for presentation at the Thirteenth Annual BIO CEO & Investor Conference

The Biotechnology Industry Organization (BIO) today announced the selection of therapeutic workshops to be presented at the Thirteenth Annual BIO CEO & Investor Conference, taking place February 14-15.

13 Jan 2011

Common disinfectant degrades water-borne viruses

A simple technique to make a common virus-killing material significantly more effective is a breakthrough from the Rice University labs of Andrew Barron and Qilin Li.

12 Jan 2011

NARSAD awards $12.6 million for mental health research

NARSAD: The Brain and Behavior Research Fund awards $12.6 million in new research grants, strengthening its investment in the most promising ideas to lead to breakthroughs in understanding and treating mental illness.

7 Jan 2011

Scientists devise new technique to make deuterium-depleted drinking water

Scientists in China are reporting development of a less expensive, more eco-friendly method for making deuterium-depleted drinking water, citing studies suggesting that it may be a more healthful form of water.

6 Jan 2011

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.

28 Dec 2010

HPV chemicals cause harm to human health, environment

Every hour, an enormous quantity and variety of manmade chemicals, having reached the end of their useful lifespan, flood into wastewater treatment plants. These large-scale processing facilities, however, are designed only to remove nutrients, turbidity and oxygen-depleting human waste, and not the multitude of chemicals put to residential, institutional, commercial and industrial use.

23 Dec 2010

Scientist discovers molecular switch controlling synthesis of ribosomes

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

23 Dec 2010

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

The American Academy of Pediatric Dentistry (AAPD), the recognized leader in children's oral health, announced today an outreach partnership with the text4baby program. The AAPD's leading pediatric oral health experts will work closely with text4baby in the dissemination of information to pregnant women and new moms about children's oral health care.

20 Dec 2010

Catalyst receives $4.0M milestone payment from Pfizer under hemophilia Factor VIIa program

Catalyst Biosciences, Inc., the leading company in the discovery and development of engineered proteases, today announced the receipt of a $4.0 million milestone payment from Pfizer Inc. under the terms of the collaboration agreement for the development of improved recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.

17 Dec 2010

CRI introduces new model of philanthropic investment to improve cancer patient care

Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization established in 1953 to advance the science of tumor immunology and foster the discovery of new cancer immunotherapies, announced today the launch of the Cancer Vaccine Acceleration Fund (CVAF), a new model of philanthropic investment and academic-industry collaboration established in partnership with the Ludwig Institute for Cancer Research Ltd (LICR) to speed the clinical development of therapeutic cancer vaccines and other immune system-based therapies.

15 Dec 2010

Report examines ways to improve care for Medicare's dual eligibles

News outlets explore different issues related to Medicare, including the impact the physician payment system has on patients' access and the particular challenges posed by people who qualify for both Medicare and Medicaid.

15 Dec 2010

60% of Americans concerned about negative health impact of beverages

A recent BeveragePulse.com study by Concept Catalysts and iModerate Research Technologies, found that 60% of Americans are concerned about the negative health impact of the beverages they drink and the majority of them will be drinking healthier beverages in the next 12 months. The study also shows that health concerns are the primary driver of recent changes in what consumers buy and drink and will remain the main driver of change for some time to come. Currently, 74% of Americans do not think that beverage companies are concerned about their health.

14 Dec 2010

Depression in mothers during pregnancy associated with higher levels of stress hormones in children

The cocktail of hormones cascading through depressed mothers' bodies may play an important role in the development of their unborn children's brains.

13 Dec 2010

No safe level of exposure to secondhand smoke

The following is a statement by Cheryl G. Healton, DrPH, President and CEO of Legacy on the U.S. Surgeon General's Report:

13 Dec 2010

NIH awards Scripps Research $2.35M to study new treatment for obesity

The Scripps Research Institute has been awarded a $2.35 million grant from the National Institutes of Health to study a new way of treating obesity as part of a national consortium with the Dana-Farber Cancer Institute.

8 Dec 2010

Research on ribosome could aid antibiotic development against MRSA infection

Theoretical biologists at Los Alamos National Laboratory have used a New Mexico supercomputer to aid an international research team in untangling another mystery related to ribosomes-those enigmatic jumbles of molecules that are the protein factories of living cells.

3 Dec 2010

Argonne researchers awarded 65 million hours of computing time on Blue Gene/P supercomputer

Four researchers at the U.S. Department of Energy's (DOE) Argonne National Laboratory lead projects that have been awarded a total of 65 million hours of computing time on Argonne's energy-efficient Blue Gene/P ("Intrepid") supercomputer. The researchers will conduct advanced simulation and analysis, performing virtual experiments that would be almost impossible and impractical in the natural world. They will also develop scalable system software needed to fully harness the power of supercomputers.

2 Dec 2010

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

First-ever selective irreversible inhibition of viral protease using targeted covalent drug

Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.